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Abstract 38 
The evolution of meticillin-resistant S. aureus (MRSA) from meticillin-susceptible S. 39 
aureus (MSSA) has been a result of accumulation of genetic elements under 40 
selection pressure from antibiotics. The traditional classification of MRSA into 41 
healthcare-associated MRSA (HA-MRSA) and community-associated MRSA (CA-42 
MRSA) is no more relevant as there is significant overlap of identical clones between 43 
these groups with an increasing recognition of human infection caused by livestock-44 
associated MRSA (LA-MRSA). Genomic studies have enabled us to model the 45 
epidemiology of MRSA along these lines. In this review, we discuss the clinical 46 
relevance of genomic studies, particularly whole genome sequencing, in 47 
investigations of outbreaks. Wealso discuss the blurring of each of the three 48 
epidemiologic groups (HA-MRSA, CA-MRSA, and LA-MRSA) demonstrating the 49 
limited relevance of this classification.  50 
 51 
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 53 
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Introduction 60 
Staphylococcus aureus is associated with a variety of diseases in humans including 61 
superficial infections, deep-seated infections, acute sepsis, respiratory infection and 62 
toxin mediated illnesses. The first clone of meticillin-resistant S. aureus (MRSA) was 63 
identified in 1961. Molecular epidemiological evidence suggests MRSA have evolved 64 
on multiple occasions from lineages of meticillin-susceptible S. aureus (MSSA) 65 
isolates. Although MRSA was initially a healthcare-associated pathogen dominated 66 
by distinct lineages and often associated with multi-drug resistance, the emergence 67 
of genetically distinct community-associated MRSA (CA-MRSA) infections in the last 68 
two decades has led to a significant clinical impact outside the hospital setting. 69 
Moreover, CA-MRSA has also become established in healthcare settings and it has 70 
been suggested that these clones will replace the healthcare-associated MRSA (HA-71 
MRSA) clones over time. In addition, CA-MRSA is slowly acquiring resistance to 72 
other antibiotics and as a result phenotypic distinctions between HA-MRSA and CA-73 
MRSA are blurring (1).  Livestock-associated MRSA (LA-MRSA) are genetically 74 
distinct from CA-MRSA and HA-MRSA, and have their main reservoir in farm 75 
animal(2). Recent reports also suggest a blurring of this epidemiology and possible 76 
transmission between of LA-MRSA humans.  77 
 78 
Genomic studies, particularly using whole genome sequencing (WGS), enhance our 79 
understanding of the key features of each MRSA type and the genetic changes 80 
associated with changing epidemiology. They also allow us to map global, national, 81 
and regional spread of variants and investigate the selective pressures that shape 82 
the population. The introduction of WGS technology into routine diagnostics in 83 
healthcare provides promise of rapid access to resistance, virulence, host-adaptation 84 
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and outbreak information, improving patient management, infection control and 85 
biosecurity.  86 
 87 
This review is a summary of the discussions that took place at the 5th International 88 
Society of Chemotherapy MRSA consensus conference (Verona in May 2014). 89 
 90 
The emergence of MRSA 91 
MRSA emerged from MSSA lineages with acquisition of the staphylococcal cassette 92 
chromosome (SCC) element that carries either mecA or mecC (SCCmec). SCC 93 
elements are large segments of DNA that carry variable arrays of genes, which can 94 
include genes that encode resistance to antibiotics other than meticillin. Diverse 95 
SCCmec types (SCCmec types I to XI) have been described (3). Acquisition of other 96 
mobile genetic elements (MGEs) carrying virulence genes and other antibiotic 97 
resistance determinants may lead to further adaptation of MRSA lineages (4). MGE 98 
encoded virulence factors such as enterotoxins, Panton-Valentine leucocidin (PVL), 99 
other bi-component leucocidins, toxic shock syndrome toxin, and staphylokinase, are 100 
carried by bacteriophages or S. aureus pathogenicity islands (SaPI) (5). A wide 101 
range of antimicrobial resistance genes can also be carried on plasmids and 102 
transposons (6). These genes can confer resistance to penicillins, macrolides, 103 
aminoglycosides, tetracyclines, chloramphenicol, fusidic acid, mupirocin, linezolid, 104 
and biocides.   105 
 106 
Molecular typing techniques such as multi locus sequence typing (MLST) have 107 
defined the S. aureus population structure (7). MLST assigns isolates to a sequence 108 
type (ST) based on the allelic profile of sequence within seven housekeeping loci. 109 
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Isolates that share five out of the seven alleles may be grouped together into clonal 110 
complexes (CCs) that describe lineages. MRSA commonly associated with human 111 
infections worldwide is due to a limited number of lineages including CC1, CC5, CC8 112 
(and related ST239), CC22, CC30, CC45, CC59 and CC80 (4). Lineages are 113 
genetically very distinct from each other with substantial variation in genes encoding 114 
for surface proteins and regulators, although they originally shared a common 115 
ancestor prior to SCCmec acquisition (8).   116 
 117 
The epidemiology of MRSA in the four decades following the identification of the first 118 
MRSA was principally associated with spread in hospitals. A handful of dominant 119 
clones account for the majority of HA-MRSA worldwide e.g. ST22 and ST36 in the 120 
United Kingdom (UK), ST239 in Asia and Australia, and ST5 in North America and in 121 
Japan and Korea. These clones were able to establish themselves by their 122 
competitive advantage in the presence of intensive antibiotic use, most notably but 123 
not restricted to β-lactams. In the late 1980s, MRSA began to emerge in the 124 
community. CA-MRSA has evolved independently of the HA-MRSA clones. In the 125 
beginning, this was mostly confined to closed communities, for example, Australian 126 
aborigines, but around the late 1990s CA-MRSA emerged worldwide in the general 127 
population. CA-MRSA clones typically possess SCCmec type IV or V elements and 128 
are often positive for the PVL toxin. Like HA-MRSA, the distribution of the 129 
predominant clones tends to be geographically distinct: ST80 in Europe and 130 
Northern Africa, ST59 in the Far East, ST93 and ST1 in Australia, and ST1 and ST8 131 
in the US.  Since 2005, MRSA from animals (LA-MRSA) have increasingly been 132 
recognized as a cause of human infections. LA-MRSA is predominantly due to the 133 
ST398 clone in Europe, whereas ST9/t899 dominates in Asia. ST398 and ST9 are 134 
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tetracycline resistant and are strongly associated with pig farms, although they are 135 
also found in a range of other farm animals. Like the HA-MRSA and CA-MRSA, 136 
evolution of meticillin resistance appears to have occurred independently; 137 
phylogenomic analysis of representatives of the LA-MRSA CC398 population 138 
suggests this lineage has descended from a human MSSA ST398 clone, which after 139 
a host jump acquired tetracycline and meticillin resistance. In this process the LA-140 
MRSA lineage lost the φSa3 phage carrying the human evasion genes sak, scn and 141 
chp (9). LA-MRSA marks a paradigm shift in the epidemiology as humans hitherto 142 
have been the dominant reservoir, tackling of LA-MRSA requires a One Health 143 
approach with collaboration of veterinarians, farmers, doctors and environmentalists. 144 
The epidemiological definitions for CA-MRSA, HA-MRSA and LA-MRSA (Table 1) 145 
may not be fit for purpose in future.  For example, Folden and colleagues reported 146 
the variation in estimating the proportion of CA-MRSA infections using 147 
epidemiological definitions: use of one set of definitions classified 5% of isolates as 148 
CA-MRSA while using another set led to as many as 49% of infections to be 149 
classified as CA-MRSA (10). In order to avoid such misclassification, the Centers for 150 
Disease Control and Prevention (CDC) has provided a definition for CA-MRSA 151 
(Table 1) (11). However, at the same time as CA-MRSA becomes common in the 152 
community, changes in hospital practice such as reduced lengths of stay, day-only 153 
admissions and hospital-in-the-home or community hospitals make application of 154 
traditional definitions difficult as facilities traditionally available in hospitals are 155 
increasingly delivered in the community in a more integrated manner. Miller and 156 
colleagues failed to label any MRSA bacteraemia (n= 57) presenting at the Oxford 157 
Radcliffe Hospital between 2003 and 2006 as caused by CA-MRSA (12). Problems 158 
are also encountered when using antibiotic susceptibility pattern or traditional genetic 159 
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signatures as an indicator of epidemiological origin. In the UK, ciprofloxacin 160 
susceptibility is used widely in the clinical laboratories as a marker for CA-MRSA but 161 
resistance pattern is variable in America where levels of ciprofloxacin resistance 162 
approaches 80% in some high-risk groups (13). Similarly, PVL detection should not 163 
be used as a sole marker for CA-MRSA (14). Genetic definitions that use the 164 
SCCmec type IV element as a marker for CA-MRSA are flawed as they potentially 165 
include the EMRSA-15 (ST22) and USA800 (ST5) clones, which are 166 
epidemiologically HA-MRSA. As the distinction between HA-MRSA and CA-MRSA 167 
becomes increasingly blurred a classification based solely on the SCCmec type IV 168 
element is no longer helpful. The identification of markers associated with different 169 
epidemiological niches becomes valuable when combined with stable genetic 170 
markers identifying the origin of a successful clone such as CC type and SCCmec 171 
type.    172 
 173 
Each MRSA clone has emerged as a result of genetic variation such as acquisition 174 
of resistance, virulence and host-adaptation genes, coupled with selective pressures 175 
such as antimicrobial usage that allow it to expand in healthcare, community and 176 
animal husbandry niches. As the number and quantity of antibiotics being used 177 
increases, so does the selective pressure exerted on the S. aureus population to 178 
develop and maintain resistance. Such conditions favour horizontal transfer of novel 179 
mobile resistance elements, and consequently have the potential to drive the 180 
emergence of a new “super bug” with a fully multi-drug resistance spectrum. For 181 
example, gene transfer from vancomycin-resistant enterococci led to the emergence 182 
of vancomycin-resistant S. aureus (15). Fortunately, the relative fitness of these 183 
isolates is thought to be compromised (16). Also alarming is the emergence of 184 
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linezolid-resistant S. aureus (LRSA) belonging to the USA300 clone possessing the 185 
cfr resistance gene. Three such isolates were identified as part of routine 186 
surveillance in the New York region (17). An outbreak of LRSA has also been 187 
reported in Spain (18).  188 
 189 
In the remainder of the paper we will further discuss the three epidemiological types 190 
of MRSA with particular reference to the contribution of genomic information to our 191 
understanding of their emergence, spread and global dissemination, virulence, and 192 
antibiotic resistance. 193 
 194 
Hospital-associated MRSA (HA-MRSA) 195 
One of the most globally prolific clones of HA-MRSA in recent years is the epidemic 196 
MRSA 15 (EMRSA-15) clone, which belongs to the ST22/CC22 lineage. EMRSA-15, 197 
first described in 1991 in England, from which point it spread rapidly all over the UK, 198 
such that 15 years later, two-thirds of all MRSA bacteraemia episodes were caused 199 
by this clone. Phylogenomic studies have proposed that pandemic MRSA CC22 200 
emerged in the mid 1980s in the UK Midlands, and coincided with the introduction of 201 
fluoroquinolone antibiotics in the UK. The acquisition of fluoroquinolone resistance 202 
by the EMRSA-15 clone through mutation was a seminal event in its emergence. 203 
This resistance pre-dated the clinical licensing of fluoroquinolones, but occurred at a 204 
time when fluoroquinolones were used in clinical studies in the UK. In support of the 205 
importance of fluoroquinolone resistance in selecting for HA-MRSA, a decline in 206 
prescribing of fluoroquinolones in the UK has been followed by the decline of MRSA 207 
in hospitals (19, 20).  208 
 209 
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Fluoroquinolone resistance is almost universal in EMRSA-15 isolates (21).  210 
However, this lineage is also capable of carrying a variety of different genes located 211 
on mobile genetic elements that confer resistance to aminoglycosides, macrolides, 212 
chloramphenicol, trimethoprim-sulphamethoxazole, fusidic acid, mupirocin, 213 
tetracycline and antiseptics, highlighting the selection pressure placed on EMRSA-15 214 
(20). Evidence of how regional prescribing regimes generate regional adaptation can 215 
be found in the genetic determinants associated with clindamycin resistance. Holden 216 
et al. examined EMRSA-15 from Germany, where clindamycin use is high, and found 217 
that the majority of isolates contain multiple independent mutations to the ermC 218 
leader peptide region rendering them resistant to clindamycin as well as 219 
erythromycin. In contrast, in the UK where the use of clindamycin is limited, all 220 
EMRSA-15 ermC leader peptides were intact, therefore making these isolates 221 
susceptible to clindamycin. The human EMRSA-15 epidemic has also spread into 222 
the companion animal population (22, 23), with veterinary hospitals also being 223 
healthcare settings that may experience high levels of transmission (24). 224 
  225 
A noticeable feature of EMRSA-15 is its propensity to spread, expand and replace 226 
the dominant HA-MRSA. EMRSA-15 overtook the previously successful CC30 HA-227 
MRSA epidemic MRSA 16 (EMRSA-16; ST36- II) clone in the UK in the early 2000s. 228 
The replacement of resident HA-MRSA clones by EMRSA-15 MRSA has been well 229 
documented in Portugal, Singapore and Australia (25-27). One feature that may 230 
contribute to its success is the SCCmec IV element that this clone carries, which has 231 
lower fitness cost than the larger SCCmec elements such as SCCmec types II and III 232 
which were prevalent in earlier HA-MRSA clones (28).  In addition, some variants of 233 
11 
 
CC22 HA-MRSA have acquired the PVL-associated genes, causing outbreaks 234 
among neonates in Australia (29), and in the UK (30). 235 
 236 
Another interesting pandemic HA-MRSA clone is ST239-MRSA-III, widespread in 237 
Australian, Asian and South American hospitals.  Epidemiological studies using 238 
WGS of global populations clearly showed that isolates were clustered into regional 239 
groups indicating localized evolution, but that transmission to other continents 240 
occurred sporadically (31). There were clear associations between isolates from 241 
countries with close cultural links such as Portugal and Brazil.  There was also 242 
evidence of direct introduction of Asian isolates to Australia (32), UK and Denmark. 243 
However, these MRSA failed to become established in hospitals in the UK and 244 
Denmark (20).  245 
 246 
Other widespread HA-MRSA clones include CC5 (predominately ST5-MRSA-II [New 247 
York/Japan MRSA/USA100] and ST5-MRSA-VI [Paediatric clone]), CC8 (ST247-248 
MRSA-I [EMRSA-17/ Iberian MRSA]), CC30 (ST36-MRSA-II [EMRSA-16/USA200]), 249 
and CC45 (ST45-MRSA-IV [Berlin MRSA/USA600]) (33). The ST5 MRSA clone has 250 
been predominant in the hospitals in America (34). Data from the Active Bacterial 251 
Core Surveillance from the CDC indicate that USA100 (ST5) is the predominant 252 
strain type although from 2004 onwards the more virulent type USA300 (ST8) 253 
isolates are increasingly recognized as a cause of hospital-associated bacteraemia 254 
(35-37). Indeed, the USA300 epidemic peaked in 2004 leading to the mathematical 255 
predictions that the USA300 CA-MRSA strains will eventually displace the HA-MRSA 256 
strains due to the survival advantage of the former as a result of smaller and fewer 257 
genes leading to enhanced fitness (38). While USA300 continues to be a 258 
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predominant clone, there are significant regional differences in the proportion of 259 
bloodstream infections caused by USA300 clone. Jenkins and colleagues found that 260 
the proportion of USA300 clone ranged from 19% to 62% of the bloodstream MRSA 261 
isolates even within Denver (39). The incidence of USA300 in invasive infections has 262 
declined since the peak in 2004 (40). Thus, while different countries and regions 263 
have different dominant clones, they also have different rates of MRSA infection, 264 
different prescribing practices, and healthcare systems, each providing unique 265 
selective pressures that have a profound effect on strain dynamics. 266 
 267 
Community-associated MRSA (CA-MRSA) 268 
CA-MRSA has been circulating in Europe since the 1990s (41-43). In the beginning, 269 
the CC80 lineage predominated the epidemiological group. The CC80 clones 270 
possess the PVL-associated genes which encode the PVL toxin. Phylogeographical 271 
analysis reveals CC80 emerged in sub-Saharan Africa in the 1980s before rapidly 272 
disseminating into Europe, most likely via coastal areas of Guinea, as a result of 273 
human migration. This imported lineage then spread throughout Europe within ten 274 
years followed by another secondary spread a few years later. At the time it was 275 
introduced into Europe the CC80 lineage contained the PVL-associated genes. 276 
Genes encoding PVL were subsequently acquired as it spread across continents. In 277 
terms of resistance to antibiotics, the African ancestor lineage was generally 278 
susceptible except for tetracycline while fusidic acid resistance was acquired 279 
following introduction into Europe where topical use of fusidic acid is widespread in 280 
some regions (44).  281 
 282 
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The American story of CA-MRSA is strikingly different. In the United States CA-283 
MRSA was first documented in children during the late nineties. The isolates 284 
belonged to a single clone, designated USA400 (belonging to CC1), and caused 285 
sepsis with pneumonia associated with high lethality. The USA400 clone has 286 
subsequently been replaced by USA300, a member of CC8, which is now the most 287 
common CA-MRSA in America. Accompanying this shift in the MRSA population 288 
was a change in the epidemiology of CA-MRSA disease; CA-MRSA are typically 289 
associated with skin and soft tissue infection. Amongst the MGEs USA300 isolates 290 
carry, is a type I arginine catabolic mobile element (ACME) containing the speG 291 
gene. The product of this gene, spermidine N-acetyl transferase, degrades host 292 
polyamines (e.g. spermidine) that are lytic to the bacteria, thus enhancing the fitness 293 
of the bacteria to survive within the host (45). Within the CC8 lineage, nine clades 294 
have been identified, designated clade CC8-A to CC8-I (46). This lineage has 295 
undergone a multiclonal expansion in contrast to the European CA-MRSA CC80, 296 
which has given rise to a single successful clone with a clear geographical pattern of 297 
emergence and spread. Some clades within the CC8 (clades CC8-A, CC8-C, CC8-D 298 
and CC8-E) population appear to be geographically diverse, whereas others are 299 
geographically restricted to a single area (e.g. clade CC8-B in Europe). The 300 
multiclonal expansion is reflected in the diverse antibiotic resistance pattern of the 301 
CC8 lineage. Some clones are fully susceptible while others are multi-resistant, 302 
particularly those belonging to CC8-E. Phylogenetic analysis reveals a stepwise 303 
incremental gain in antibiotic resistance genes. The older representatives of CC8-E 304 
population harbour resistance to as many as nine antibiotics while the newer clades 305 
such as clade CC8-A are pauci-resistant (resistance often limited to two antibiotics).  306 
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This appears to support the hypothesis that USA300may be on the same trajectory 307 
as CC8-E was at one point in its evolutionary history, and could in the future become 308 
multi-resistant. Clade CC8-A also carries the PVL-associated genes and contains 309 
isolates that belong to the USA300. In a study investigating the genomics of 310 
USA300, Uhlemann et al. found evidence for at least five different acquisitions of the 311 
lukSF-carrying prophage into the ST8 population, but only a single event into 312 
USA300 clone (47). From their phylogenomic analysis the authors concluded that 313 
the acquisition of the lukSF-carrying prophage coincided with the acquisition of 314 
ACME, and occurred between 1970 and 1993, resulting in the emergence of 315 
USA300. The USA300 clone has spread to other continents including Europe and 316 
South America (48). The expansion of USA300 in Europe may have occurred as a 317 
single point introduction followed by spread or by multiple introductions over a long 318 
period of time followed by limited spread on each occasion. WGS data on the French 319 
isolates reveal that following multiple introductions, the lineage has stabilized and 320 
may even decline (49).  321 
 322 
Another clinically relevant gene associated with USA300 clone is the msrA gene 323 
encoding resistance to macrolides and streptogramins. This gene is carried on the 324 
rep16 plasmid, and at least eight rep family plasmids have been identified within the 325 
CC8 lineage. The rep16 plasmid was acquired more recently, when it replaced the 326 
rep20 plasmid typical of the older isolates within clade A (46). A feature of the CA-327 
MRSA in the US is high levels of genetic variation. Carpaij and colleagues found 328 
great diversity related to acquisition of genes among 13 subtype USA300-0114 329 
isolates isolated over a short period of one month from one single location, which 330 
suggests ongoing evolution of the clone (50).  331 
15 
 
In keeping with their geographical isolation, the epidemiology of CA-MRSA in 332 
Australia and New Zealand is unique. One of the earliest reports of CA-MRSA was 333 
from this region when infections caused by ST8 MRSA clone were reported amongst 334 
indigenous communities in Western Australia (51). Later, ST30 CA-MRSA infections 335 
were reported from New Zealand and more recently non-pigmented CC75 from 336 
Northern Australia. CC75 is sufficiently different from the other S. aureus lineages to 337 
an extent that a new species name has been proposed: S. argenteus (52, 53). The 338 
other CA-MRSA lineages identified in the Australian survey include ST93-MRSA-IV, 339 
ST30-MRSA-IV, ST1-MRSA-IV, ST45-MRSA-IV, ST78-MRSA-IV, and ST5-MRSA-IV 340 
(denoted by sequence type followed by SCCmec carriage). The CA-MRSA type that 341 
now predominates in New Zealand is the fusidic-acid resistant ST5-MRSA-IV clone. 342 
(54).  343 
 344 
The full epidemiological picture in Asia and Africa is unclear as data are lacking from 345 
many regions and from prior to the turn of the century. The dominant Asian clones 346 
include ST59-MRSA-IV/V in China, Taiwan, Singapore, and Hong Kong, ST72-347 
MRSA-IV in Korea, ST30-MRSA-IV in Japan and the Western Pacific, ST80-MRSA-348 
IV in the Middle East, and the PVL positive Bengal Bay clone ST772-MRSA-V in 349 
India. The latter clone has since been reported from various countries in Europe, 350 
Middle East, and Australasia. Closely related to the CC1 lineage with, the ST772 has 351 
several distinguishing features such as resistance to multiple antibiotics, different agr 352 
group (group II), and capsule type 5 rather than 8 (55). The African origin of the 353 
European CA-MRSA clone has been well described, and CA-MRSA has been 354 
reported from Egypt, Mali, Algeria, and Nigeria. Sampling of individuals from the 355 
remote Babongo tribes in Gabon found a high percentage (55%) of PVL positive 356 
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clones of MSSA, but MRSA was not detected in any of the samples. The MSSA 357 
clones found in this study include the common clonal lineages CC1, CC5, CC30, and 358 
CC80, despite the remote location of this tribal population (56).  359 
 360 
Livestock-associated MRSA (LA-MRSA) 361 
Infections with LA-MRSA can occur in people who have direct contact to farm 362 
animals in factory farms (especially pig and poultry production systems).  This 363 
affects, for example, farmers, veterinarians or slaughterhouse employees.  MRSA 364 
was first described in animals in 1972 when it was found in a cow (57). However, it 365 
was not until 2005 when CC398 MRSA was reported from pigs in both France and 366 
The Netherlands that livestock was shown to be an important zoonotic reservoir for 367 
MRSA. Pigs are the main reservoir for CC398 but this clone has also been found in 368 
veal calves (especially in The Netherlands and Belgium), poultry, horses, and to a 369 
lesser extent in dairy cows. In addition, CC398 has been found in pets such as dogs 370 
and cats, as well as in rodents. There is a general consensus that the prevalence of 371 
CC398 is increasing rapidly worldwide. However, precise information on the true 372 
prevalence of CC398 in animals is difficult to obtain. In The Netherlands it is 373 
estimated that >80% of all farms are MRSA positive. In Denmark, a recent 374 
surveillance study showed that 60-70% of all pig herds are positive, whereas in 375 
Norway only very few farms have been found positive. However, in most other 376 
countries no systematic surveillance on CC398 or other types of LA-MRSA is 377 
performed in animals (the same holds true for the surveillance of these strains in 378 
humans).  379 
 380 
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While CC398 MRSA is the overwhelmingly dominant lineage in livestock in Europe, 381 
CC9 MRSA is the predominant type in Southeast Asia. In addition to these two 382 
clonal complexes, a number of other MRSA lineages including CC1, CC5, CC97, 383 
CC121, CC130, and ST425 have been reported from livestock (58). MRSA 384 
belonging to CC130 and ST425 are meticillin resistant due to the recently described 385 
mecC gene instead of the mecA gene. The mecC gene only has approximately 70% 386 
similarity to the mecA gene (59). As a result, the molecular diagnostic assays need 387 
to encompass primers for both types. CC97, a widely disseminated human CA-388 
MRSA type, is also interesting as it descended from bovine MSSA and has acquired 389 
SCCmec after the bovine-to-human host adaptation. This is in contrast with the 390 
livestock clade of CC398 that acquired SCCmec after jumping from humans to pigs 391 
(9, 60).  392 
 393 
The risk factors for transmission between herds are not fully elucidated. Trade of 394 
MRSA positive pigs is the most important risk factor. However, several herds have 395 
been found positive without acquisition of new animals for many years prior to the 396 
detection of MRSA CC398. In these cases, introduction from MRSA-positive humans 397 
(such as veterinarians or new employees), or from rodents, are possible 398 
transmission routes. Within herds, use of antimicrobials, particularly β-lactams and 399 
tetracyclines, and trace metals including zinc are important selective pressures (61). 400 
The latter is substantiated in the dominant SCCmec V (5C2&5) cassette which 401 
includes the crzC gene (62).   402 
 403 
By far the most important risk factor for LA-MRSA in humans is repeated direct 404 
occupational contact to animals positive for MRSA. The extent of the risk is 405 
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dependant both on contact time and contact intensity. In Denmark, 70% of all new 406 
cases found in 2013 reported direct contact with pigs, and an additional 17% were 407 
household members of persons with close contact with live pigs. Of the remaining 408 
13% with no pig contact, the majority of cases lived in rural areas with high pig 409 
density whereas few occurred in urban areas. This indicates that transmission 410 
occurs via local spill over from persons working at livestock farms or through contact 411 
with the farm environment itself rather than through a generalized spread in the 412 
community (63). The relative contribution of transmission via the environment or via 413 
humans in contact with pigs is unknown. However, based on knowledge of 414 
transmission of S. aureus in other settings, transmission through human to human 415 
contact is likely to predominate (64).  416 
 417 
As MRSA has been found on meat in 10-20% of samples tested on many occasions, 418 
there have been reports in the lay press on the risk of acquisition of MRSA via the 419 
food chain. The epidemiology on LA-MRSA, however, clearly shows that meat is not 420 
an important route of transmission. If it were the case, one would see a very different 421 
geospatial distribution among cases not associated with pig contact (63). Further 422 
evidence against this route of transmission is provided by the low incidence of LA-423 
MRSA found in slaughterhouse workers. There may be some risk of acquisition of 424 
MRSA as a result of handling of meat, rather than ingestion, but this risk is not 425 
significant and clearly has not been associated with wide-spread transmission. 426 
Washing hands immediately after handling food is a very effective way to block 427 
transmission. 428 
 429 
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The increasing reservoir of LA- MRSA in pigs, and in humans in direct contact with 430 
pigs, results in increasing number of cases in the general community, particularly in 431 
immunocompromised individuals. Therefore, unless this epidemic is contained, it is 432 
likely that we will see increasing numbers of severe infections due to LA-MRSA. 433 
Köck et al. reported that 16 out 194 (8%) MRSA bacteraemia episodes in Germany 434 
diagnosed during years 2008-2012 were due to MRSA CC398 (65). Furthermore, the 435 
greater the human carriage of LA-MRSA clones, the greater the risk that these 436 
clones will undergo adaptation enhancing human-to-human transmissibility.  437 
Measures to counteract the expanding reservoir in pigs are thus urgently needed, as 438 
are measures to lower the bacterial burden in the farm environment. 439 
 440 
Application of genomics in epidemiological settings and outbreak 441 
investigations 442 
Modern genetic tools have greatly expanded our knowledge of the epidemiology of 443 
MRSA infection, and allowed a closer examination of outbreaks in the hospital and in 444 
the community. Classical typing methods or antibiogram may not have sufficient 445 
resolution power to link MRSA clones during outbreak investigation. For example, 446 
WGS has been used retrospectively in an outbreak in Special Care Baby Unit in a 447 
Cambridge hospital (66). Of the 17 cases in the unit over a six-month period, 12 448 
appeared to be linked based on identical or near-identical antibiotic susceptibility 449 
pattern. However, WGS data revealed that 14 of the 17 isolates belonged to a new 450 
type, ST2371 (a single locus variant of ST22 that possesses the PVL-associated 451 
genes). Thus, only three of the five isolates excluded as a result of antibiogram 452 
mismatch were correctly excluded: the remaining two were in fact associated with 453 
the outbreak. Also, the sequencing data identified additional cases, both 454 
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retrospectively and prospectively, linked to the outbreak but beyond the parameters 455 
of the outbreak as defined in the traditional infection control investigations. Following 456 
a new case more than two months after the outbreak was thought to have ceased, 457 
screening of staff identified a single MRSA carrier. WGS of colonies of S. aureus 458 
from this individual identified genetic overlap in the colonising population of the staff 459 
member and the outbreak population. The application of WGS for the near real time 460 
analysis of outbreaks has great utility. Moreover, the technique encompasses the 461 
information provided by the more traditional genotyping tools such as sequence 462 
typing coupled with detection of specific genes such as those encoding PVL toxin 463 
and other virulence determinants. The rapid detection of genes associated with 464 
pathogenicity, transmission and resistance may help in limiting spread within 465 
hospitals by timely adherence to strict infection control protocols, and may also help 466 
in characterizing atypical clones that pose a threat. These clones may be 467 
misreported in routine clinical laboratories. Recent sequencing work on four clones 468 
from Scotland identified several single nucleotide substitutions in the transpeptidase 469 
domains of PBPs 1, 2 and 3 which can explain resistance to β-lactamase-stable 470 
penicillins (67). Transmission of MRSA in the setting of deceased donor liver 471 
transplant was confirmed by using WGS in a recent report (68). The diagnostic value 472 
of WGS cannot be overemphasized.  473 
 474 
WGS has also been used for understanding of epidemiology and transmission 475 
dynamics of MRSA by creating a sequencing database. Based on the numbers of 476 
single nucleotide polymorphism (SNP) and their dispersion within the genome it is 477 
possible to discriminate between the timing of acquisition and the relationship 478 
between isolates. Bartels and colleagues found 59 SNP differences between two 479 
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isolates belonging to the ST80 clone from the same household which indicates long 480 
term carriage based on the fact that SNPs are acquired at a predictable rate (69). 481 
Application of WGS in human infections with MRSA carrying the mecC gene 482 
identified two distinct clusters with transmission confined between individuals and 483 
their livestock with only small differences in SNPs between the animal and the 484 
human isolates, which supports zoonotic transmission. MLST, pulse-field gel 485 
electrophoresis and multilocus variable number tandem repeat analysis were unable 486 
to distinguish between the two clusters (70).   487 
 488 
489 
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Conclusion 490 
The story of MRSA is one of dramatic recent success driven by the widespread use 491 
of antibiotics. S. aureus clones have co-evolved with humans, and MRSA have 492 
emerged from the population on multiple occasions. The rapid spread of MRSA has 493 
been aided by human migration, which itself has reached a level never seen before 494 
in the history of mankind. MRSA has adapted to the environments and conditions 495 
that humans have created and where they have thrived. Clones have jumped from 496 
one host species to another, have amplified in the niche areas, and then gone back 497 
to colonize the population where it emerged while still retaining a strong foothold in 498 
specialized environments. There is significant overlap between clones across the 499 
traditional groups (HA-MRSA and CA-MRSA) and also some blurring of the groups 500 
themselves as healthcare is increasingly delivered in the community. Newer 501 
technologies like WGS will lead to a better epidemiological understanding of MRSA. 502 
Use of antibiotics in humans and livestock has given this highly adaptive species a 503 
survival advantage, as it is easily able to acquire resistance. S. aureus has not lost 504 
its virulence either, as it continues to be a primary human pathogen with significant 505 
mortality associated with invasive disease.  506 
 507 
Declarations 508 
Funding: No direct funding. This review is based on the discussions that took place 509 
at the 5th MRSA consensus conference held in Verona in May 2014. The conference 510 
was supported by the International Society of Chemotherapy. 511 
Competing interests: No 512 
Ethical approval: Not required 513 
 514 
23 
 
References 515 
(1) David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus 516 
aureus: epidemiology and clinical consequences of an emerging epidemic. Clin 517 
Microbiol Rev 2010;23:616-687. 518 
(2) Smith TC. Livestock-associated Staphylococcus aureus: the United States 519 
experience. PLoS Pathog 2015;11:e1004564. 520 
(3)Hiramatsu K, Ito T, Tsubakishita S, Sasaki T, Takeuchi F, Morimoto Y, et al. 521 
Genomic Basis for Methicillin Resistance in Staphylococcus aureus. Infect 522 
Chemother 2013;45:117-136. 523 
(4) Lindsay JA. Genomic variation and evolution of Staphylococcus aureus. Int J 524 
Med Microbiol 2010;300:98-103. 525 
(5) Malachowa N, DeLeo FR. Mobile genetic elements of Staphylococcus aureus 526 
Cell Mol Life Sci 2010;67:3057-3071. 527 
(6) Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, et al. 528 
Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus 529 
aureus Science. 2003;302:1569-1571. 530 
(7) Saunders NA, Holmes A. Multilocus sequence typing (MLST) of Staphylococcus 531 
aureus. Methods Mol Biol 2007;391:71-85.  532 
(8) Kreiswirth B, Kornblum J, Arbeit RD, Eisner W, Maslow JN, McGeer A et al. 533 
Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus 534 
Science 1993; 259: 227-230.  535 
(9)Price LB, Stegger M, Hasman H, Aziz M, Larsen J, Andersen PS, et al. 536 
Staphylococcus aureus CC398: host adaptation and emergence of methicillin 537 
resistance in livestock. MBio 2012;3:00305-11. 538 
24 
 
(10) Folden DV, Machayya JA, Sahmoun AE, Beal JR, Holzman GS, Helgerson SD, 539 
et al. Estimating the proportion of community-associated methicillin-resistant 540 
Staphylococcus aureus: two definitions used in the USA yield dramatically different 541 
estimates. J Hosp Infect 2005;60:329-332. 542 
(11) Otter JA, French GL. Community-associated meticillin-resistant Staphylococcus 543 
aureus: the case for a genotypic definition. J Hosp Infect 2012;81:143-148. 544 
(12) Miller R, Esmail H, Peto T, Walker S, Crook D, Wyllie D. Is MRSA admission 545 
bacteraemia community-acquired? A case control study. J Infect 2008;56:163-170. 546 
(13 )Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG, Han LL, et al. 547 
Emergence of multidrug-resistant, community-associated, methicillin-resistant 548 
Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern 549 
Med 2008;148:249-257. 550 
(14) Rossney AS, Shore AC, Morgan PM, Fitzgibbon MM, O'Connell B, Coleman 551 
DC. The emergence and importation of diverse genotypes of methicillin-resistant 552 
Staphylococcus aureus (MRSA) harboring the Panton-Valentine leukocidin gene 553 
(pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland 554 
J Clin Microbiol 2007;45:2554-2563. 555 
(15) Bartley J. First case of VRSA identified in Michigan. Infect Control Hosp 556 
Epidemiol 2002;23:480. 557 
(16) Livermore D. The zeitgeist of resistance. J Antimicrob Chemother 2007;60 558 
Suppl 1:i59-61. 559 
(17) Locke JB, Zuill DE, Scharn CR, Deane J, Sahm DF, Goering RV, et al. 560 
Identification and Characterization of Linezolid-Resistant cfr-Positive Staphylococcus 561 
aureus USA300 Isolates from a New York City Medical Center. Antimicrob Agents 562 
Chemother 2014;58:6949-6952. 563 
25 
 
(18) Sanchez Garcia M, De la Torre MA, Morales G, Pelaez B, Tolon MJ, Domingo 564 
S, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive 565 
care unit. JAMA 2010;303:2260-2264. 566 
(19) Liebowitz LD, Blunt MC. Modification in prescribing practices for third-generation 567 
cephalosporins and ciprofloxacin is associated with a reduction in meticillin-resistant 568 
Staphylococcus aureus bacteraemia rate. J Hosp Infect 2008;69:328-336. 569 
(20) Knight GM, Budd EL, Whitney L, Thornley A, Al-Ghusein H, Planche T, et al. 570 
Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus 571 
(HA-MRSA) clones over time. J Antimicrob Chemother 2012;67:2514-2522. 572 
(21) Holden MT, Hsu LY, Kurt K, Weinert LA, Mather AE, Harris SR et al. A genomic 573 
portrait of the emergence, evolution, and global spread of a methicillin-resistant 574 
Staphylococcus aureus pandemic. Genome Res 2013;23:653-664. 575 
(22)Harrison EM, Weinert LA, Holden MT, Welch JJ, Wilson K, Morgan FJ, et al. A 576 
shared population of epidemic methicillin-resistant Staphylococcus aureus 15 577 
circulates in humans and companion animals. MBio 2014;5:e00985-13. 578 
(23) Loeffler A, Pfeiffer DU, Lloyd DH, Smith H, Soares-Magalhaes R, Lindsay JA. 579 
Meticillin-resistant Staphylococcus aureus carriage in UK veterinary staff and owners 580 
of infected pets: new risk groups. J Hosp Infect 2010;74:282-288. 581 
(24) Paterson GK, Harrison EM, Murray GG, Welch JJ, Warland JH, Holden MT, et 582 
al. Capturing the cloud of diversity reveals complexity and heterogeneity of MRSA 583 
carriage, infection and transmission. Nat Commun 2015;6:6560. 584 
(25) Aires-de-Sousa M, Correia B, de Lencastre H, Multilaboratory Project 585 
Collaborators. Changing patterns in frequency of recovery of five methicillin-resistant 586 
Staphylococcus aureus clones in Portuguese hospitals: surveillance over a 16-year 587 
period. J Clin Microbiol 2008;46:2912-2917. 588 
26 
 
(26) Hsu LY, Harris SR, Chlebowicz MA, Lindsay JA, Koh TH, Krishnan P, et al. 589 
Evolutionary dynamics of methicillin-resistant Staphylococcus aureus within a 590 
healthcare system. Genome Biol 2015;16:81. 591 
(27) Coombs GW, Nimmo GR, Daly DA, Le TT, Pearson JC, Tan HL, et al. 592 
Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013. 593 
Commun Dis Intell Q Rep 2014;38:E309-319. 594 
(28) Knight GM, Budd EL, Lindsay JA. Large mobile genetic elements carrying 595 
resistance genes that do not confer a fitness burden in healthcare-associated 596 
meticillin-resistant Staphylococcus aureus. Microbiology 2013;159:1661-1672. 597 
(29) Pinto AN, Seth R, Zhou F, Tallon J, Dempsey K, Tracy M, et al. Emergence and 598 
control of an outbreak of infections due to Panton-Valentine leukocidin positive, 599 
ST22 methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. 600 
Clin Microbiol Infect 2013;19:620-627. 601 
(30) Boakes E, Kearns AM, Ganner M, Perry C, Warner M, Hill RL, et al. Molecular 602 
diversity within clonal complex 22 methicillin-resistant Staphylococcus aureus 603 
encoding Panton-Valentine leukocidin in England and Wales. Clin Microbiol Infect 604 
2011;17:140-145. 605 
(31) Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N, et al. 606 
Evolution of MRSA during hospital transmission and intercontinental spread. Science 607 
2010;327:469-474. 608 
(32) Baines SL, Holt KE, Schultz MB, Seemann T, Howden BO, Jensen SO, et al. 609 
Convergent adaptation in the dominant global hospital clone ST239 of methicillin-610 
resistant Staphylococcus aureus. MBio 2015;6:e00080. 611 
27 
 
(33) Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H, et al. 612 
Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and 613 
harmonisation of typing methods. Int J Antimicrob Agents 2012;39:273-282. 614 
(34) David MZ, Cadilla A, Boyle-Vavra S, Daum RS. Replacement of HA-MRSA by 615 
CA-MRSA infections at an academic medical center in the midwestern United 616 
States, 2004-5 to 2008. PLoS One 2014;9:e92760. 617 
(35) Patel M, Waites KB, Hoesley CJ, Stamm AM, Canupp KC, Moser SA. 618 
Emergence of USA300 MRSA in a tertiary medical centre: implications for 619 
epidemiological studies. J Hosp Infect 2008;68:208-213. 620 
(36) Richter SS, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Kroeger JS, et al. 621 
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates 622 
collected from 43 medical centers in the United States in 2009. Antimicrob Agents 623 
Chemother 2011;55:4154-4160. 624 
(37) Tenover FC, Tickler IA, Goering RV, Kreiswirth BN, Mediavilla JR, Persing DH, 625 
et al. Characterization of nasal and blood culture isolates of methicillin-resistant 626 
Staphylococcus aureus from patients in United States Hospitals. Antimicrob Agents 627 
Chemother 2012;56:1324-1330. 628 
(38) D'Agata EM, Webb GF, Horn MA, Moellering RC,Jr, Ruan S. Modeling the 629 
invasion of community-acquired methicillin-resistant Staphylococcus aureus into 630 
hospitals. Clin Infect Dis 2009;48:274-284. 631 
(39) Jenkins TC, McCollister BD, Sharma R, McFann KK, Madinger NE, Barron M, et 632 
al. Epidemiology of healthcare-associated bloodstream infection caused by USA300 633 
strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Infect 634 
Control Hosp Epidemiol 2009;30:233-241. 635 
28 
 
(40) Tattevin P, Schwartz BS, Graber CJ, Volinski J, Bhukhen A, Bhukhen A, et al. 636 
Concurrent epidemics of skin and soft tissue infection and bloodstream infection due 637 
to community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 638 
2012;55:781-788. 639 
(41) Wannet WJ, Spalburg E, Heck ME, Pluister GN, Tiemersma E, Willems RJ, et 640 
al. Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying 641 
Panton-Valentine leucocidin genes in The Netherlands. J Clin Microbiol 642 
2005;43:3341-3345. 643 
(42) Larsen AR, Bocher S, Stegger M, Goering R, Pallesen LV, Skov R. 644 
Epidemiology of European community-associated methicillin-resistant 645 
Staphylococcus aureus clonal complex 80 type IV strains isolated in Denmark from 646 
1993 to 2004. J Clin Microbiol 2008;46:62-68. 647 
(43) Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. Community-acquired 648 
methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis 2002;8:602-649 
607. 650 
(44) Stegger M, Wirth T, Andersen PS, Skov RL, De Grassi A, Simoes PM, et al. 651 
Origin and evolution of European community-acquired methicillin-resistant 652 
Staphylococcus aureus. MBio 2014;5:e01044-14. 653 
(45) Thurlow LR, Joshi GS, Richardson AR. Virulence strategies of the dominant 654 
USA300 lineage of community-associated methicillin-resistant Staphylococcus 655 
aureus (CA-MRSA). FEMS Immunol Med Microbiol 2012;65:5-22. 656 
(46) Strommenger B, Bartels MD, Kurt K, Layer F, Rohde SM, Boye K, et al. 657 
Evolution of methicillin-resistant Staphylococcus aureus towards increasing 658 
resistance. J Antimicrob Chemother 2014;69:616-622. 659 
29 
 
(47) Uhlemann AC, Dordel J, Knox JR, Raven KE, Parkhill J, Holden MT, et al. 660 
Molecular tracing of the emergence, diversification, and transmission of S. aureus 661 
sequence type 8 in a New York community. Proc Natl Acad Sci U S A 662 
2014;111:6738-6743. 663 
(48) Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain 664 
USA300: origin and epidemiology J Antimicrob Chemother 2009;64:441-446. 665 
(49) Glaser P, Martins-Simões P, Villain A, Barbier M, Tristan A, Bouchier C et al. 666 
Demography and Intercontinental Spread of the USA300 Community-Acquired 667 
Methicillin-Resistant Staphylococcus aureus Lineage. MBio 2016;7: e02183-15.  668 
(50) Carpaij N, Willems RJ, Rice TW, Weinstein RA, Hinds J, Witney AA, et al. 669 
Genetic variation in spatio-temporal confined USA300 community-associated MRSA 670 
isolates: a shift from clonal dispersion to genetic evolution? PLoS One 671 
2011;6:e16419. 672 
(51) Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of 673 
methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 674 
1993;25:97-108. 675 
(52) Holt DC, Holden MT, Tong SY, Castillo-Ramirez S, Clarke L, Quail MA, et al. A 676 
very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment 677 
staphyloxanthin. Genome Biol Evol 2011;3:881-895. 678 
(53) Tong SY, Sharma-Kuinkel BK, Thaden JT, Whitney AR, Yang SJ, Mishra NN, et 679 
al. Virulence of endemic nonpigmented northern Australian Staphylococcus aureus 680 
clone (clonal complex 75, S. argenteus) is not augmented by staphyloxanthin. J 681 
Infect Dis 2013;208:520-527. 682 
(54) Williamson DA, Monecke S, Heffernan H, Ritchie SR, Roberts SA, Upton A, et 683 
al. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-684 
30 
 
resistant Staphylococcus aureus: a cautionary tale. Clin Infect Dis 2014;59:1451-685 
1454. 686 
(55) Monecke S, Baier V, Coombs GW, Slickers P, Ziegler A, Ehricht R. Genome 687 
sequencing and molecular characterisation of Staphylococcus aureus ST772-MRSA-688 
V, "Bengal Bay Clone". BMC Res Notes 2013;6:548. 689 
(56) Schaumburg F, Kock R, Friedrich AW, Soulanoudjingar S, Ngoa UA, von Eiff C, 690 
et al. Population structure of Staphylococcus aureus from remote African Babongo 691 
Pygmies. PLoS Negl Trop Dis 2011;5:e1150. 692 
(57) Devriese LA, Hommez J. Epidemiology of methicillin-resistant Staphylococcus 693 
aureus in dairy herds. Res Vet Sci. 1975;19:23-27.  694 
(58) Fitzgerald JR. Livestock-associated Staphylococcus aureus: origin, evolution 695 
and public health threat. Trends Microbiol 2012;20:192-198. 696 
(59) Garcia-Alvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, Curran MD, et 697 
al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in 698 
human and bovine populations in the UK and Denmark: a descriptive study. Lancet 699 
Infect Dis 2011;11:595-603. 700 
(60) Spoor LE, McAdam PR, Weinert LA, Rambaut A, Hasman H, Aarestrup FM, et 701 
al. Livestock origin for a human pandemic clone of community-associated methicillin-702 
resistant Staphylococcus aureus. MBio 2013;4:00356-13. 703 
(61) Moodley A, Nielsen SS, Guardabassi L. Effects of tetracycline and zinc on 704 
selection of methicillin-resistant Staphylococcus aureus (MRSA) sequence type 398 705 
in pigs. Vet Microbiol 2011;152:420-423. 706 
(62) Cavaco LM, Hasman H, Stegger M, Andersen PS, Skov R, Fluit AC, et al. 707 
Cloning and occurrence of czrC, a gene conferring cadmium and zinc resistance in 708 
31 
 
methicillin-resistant Staphylococcus aureus CC398 isolates. Antimicrob Agents 709 
Chemother 2010;54:3605-3608. 710 
(63) Larsen J, Petersen A, Sørum M, Stegger M, van Alphen L, Valentiner-Branth P, 711 
et al. Meticillin-resistant Staphylococcus aureus CC398 is an increasing cause of 712 
disease in people with no livestock contact in Denmark, 1999 to 2011. Euro Surveill 713 
2015; 20 (37): pii=30021. DOI: http://dx.doi.org/10.2807/1560-714 
7917.ES.2015.20.37.30021.  715 
(64) Lekkerkerk WS, van Wamel WJ, Snijders SV, Willems RJ, van Duijkeren E, 716 
Broens EM, et al. What Is the Origin of Livestock-Associated Methicillin-Resistant 717 
Staphylococcus aureus Clonal Complex 398 Isolates from Humans without Livestock 718 
Contact? An Epidemiological and Genetic Analysis. J Clin Microbiol 2015;53:1836-719 
1841. 720 
(65) Kock R, Schaumburg F, Mellmann A, Koksal M, Jurke A, Becker K, et al. 721 
Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes 722 
of human infection and colonization in Germany. PLoS One 2013;8:e55040. 723 
(66) Harris SR, Cartwright EJ, Torok ME, Holden MT, Brown NM, Ogilvy-Stuart AL, 724 
et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant 725 
Staphylococcus aureus: a descriptive study. Lancet Infect Dis 2013;13:130-136. 726 
(67) Ba X, Harrison EM, Edwards GF, Holden MT, Larsen AR, Petersen A, et al. 727 
Novel mutations in penicillin-binding protein genes in clinical Staphylococcus aureus 728 
isolates that are methicillin resistant on susceptibility testing, but lack the mec gene. 729 
J Antimicrob Chemother 2014;69:594-597. 730 
(68) Altman DR, Sebra R, Hand J, Attie O, Deikus G, Carpini KW et al. Transmission 731 
of methicillin-resistant Staphylococcus aureus via deceased donor liver 732 
32 
 
transplantation confirmed by whole genome sequencing. Am J Transplant. 733 
2014;14:2640-2644. 734 
(69)Bartels MD, Larner-Svensson H, Meiniche H, Kristoffersen K, Schonning K, 735 
Nielsen JB et al. Monitoring meticillin resistant Staphylococcus aureus and its spread 736 
in Copenhagen, Denmark, 2013, through routine whole genome sequencing. Euro 737 
Surveill 2015;20: 21112.  738 
(70) Harrison EM, Paterson GK, Holden MT, Larsen J, Stegger M, Larsen AR et al. 739 
Whole genome sequencing identifies zoonotic transmission of MRSA isolates with 740 
the novel mecA homologue mecCEMBO Mol Med 2013;5:509-515. 741 
 742 
 743 
 744 
 745 
 746 
 747 
 748 
 749 
 750 
 751 
 752 
 753 
 754 
 755 
 756 
33 
 
Table 1: Definitions of community-associated, hospital-associated and livestock 757 
associated MRSA 758 
 759 
MRSA Definition and/or salient features 
  
HA-MRSA Identified more than 48 hours after admission to a healthcare 
facility or MRSA identified in an individual with history of MRSA 
infection or colonization, admission to a healthcare facility, 
dialysis, surgery or insertion of indwelling devices in the past year. 
CA-MRSA Identified in the outpatient setting or within 48 hours following 
hospital admission in an individual with no medical history of 
MRSA infection or colonization, admission to a healthcare facility, 
dialysis, surgery or insertion of indwelling devices in the past year. 
LA-MRSA No formal definition. Usually belong to CC398 lineage in Europe 
but often CC9 in Asia. Acquired via occupational contact with 
livestock.  
 760 
